Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Axel C Mühlbacher, Matthias Nübling

Abstract

Against the background of patient involvement, understanding patients' preferences for treatments is crucial: Do physicians have the same or a different perception of the patients' preferences? As there is currently no cure for patients with multiple myeloma, primary objectives of treatment are to extend survival at the best possible quality of life. In this study, physicians' beliefs about patients' preferences regarding the treatment of multiple myeloma (MM) were explored in a direct assessment and a discrete choice experiment (DCE), and were compared to the previously explored patients' views. How much do physicians know about their patients' preferences? In a preceding study with German multiple myeloma patients, relevant attributes of an ideal multiple myeloma treatment were collected by reviewing the literature and by conducting a qualitative study with focus groups. The attributes were analyzed using both a direct measurement (16 items on a five-point Likert scale) and a DCE (eight pairs with eight characteristics). For the present study, 30 German physicians reviewed the treatment attributes from the previous study for completeness. A total of 243 physicians participated in the study (including the 30 participants in th...Continue Reading

References

Feb 13, 2001·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·M Hughes Gaston
Jan 31, 2002·The Journal of School Health·M K Tappe, R A Galer-Unti
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Jan 13, 2006·The Oncologist·Jesús San MiguelHeinz Ludwig
Jan 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominique DuboisChristine de la Loge
Jun 20, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Moeremans, L Annemans
Jan 30, 2007·Social Science & Medicine·Emily LancsarTerry Flynn
Jul 16, 2008·PharmacoEconomics·Emily Lancsar, Jordan Louviere

❮ Previous
Next ❯

Citations

Mar 27, 2013·Applied Health Economics and Health Policy·Axel C Mühlbacher, Christin Juhnke
Jul 10, 2014·PharmacoEconomics·Michael D ClarkEsther W de Bekker-Grob
Sep 13, 2014·Biological & Pharmaceutical Bulletin·Takashi KawaguchiSakae Unezaki
Dec 27, 2015·Journal of Medical Economics·Marchetti Monia
Aug 27, 2014·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Inger M JanssenFülöp Scheibler
Dec 15, 2015·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Tsung-Tai ChenKuo-Piao Chung
Mar 20, 2016·Applied Health Economics and Health Policy·Axel Mühlbacher, F Reed Johnson
Jul 19, 2013·Health Economics·Jinhu LiGioia Buckley
Oct 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Laure BenjaminGwenaëlle Vidal-Trécan
Jan 8, 2013·Journal of Affective Disorders·Thomas M ZimmermannAnette Wolfrath
Jul 14, 2016·British Journal of Haematology·Kwee YongMichele Cavo
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanya M WildesSascha A Tuchman
Mar 8, 2019·Journal of Oncology Practice·Jason RotterStephanie B Wheeler
Apr 1, 2019·Clinical Pharmacology and Therapeutics·Tommi TervonenLawrence D Phillips
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Ashley RoskoAngela Dispenzieri
Feb 20, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Marcelo Kremenchutzky, Len Walt
May 1, 2015·Expert Review of Endocrinology & Metabolism·Wendy Sacks, Glenn D Braunstein
Aug 18, 2020·Patient Preference and Adherence·Simon FiferSarah Richard
Nov 4, 2020·The Patient·Alison PearceStirling Bryan
Mar 7, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Daniel R RichardsonJohn F P Bridges
Nov 19, 2020·Patient Preference and Adherence·Katy E TrinkleyDaniel D Matlock
May 6, 2021·The Patient·Hannah CollacottSebastian Heidenreich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.